Last updated: February 15, 2022
Sponsor: Gazi University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Rheumatoid Arthritis
Musculoskeletal Diseases
Joint Injuries
Treatment
N/AClinical Study ID
NCT05240326
2021-730
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18-65 years old
- Being diagnosed according to the American College of Rheumatology (ACR)/EULAR 2010rheumatoid arthritis diagnostic criteria
- under standard medications
Exclusion
Exclusion Criteria:
- orthopedic or neurological disease with a potential to affect functional capacity
- have problems that can prevent evaluation
- have a neurological problem that may cause hearing or vision impairment
- changes in medical treatment in the last 3 months
- have high disease activity score (DAS-28>3.2)
Study Design
Total Participants: 30
Study Start date:
March 15, 2022
Estimated Completion Date:
March 15, 2024
Study Description
Connect with a study center
Gazi University
Ankara,
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.